REMS No Longer Necessary for Rosiglitazone-Containing Diabetes Drugs (FREE)

By Kristin J. Kelley Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM The Risk Evaluation and Mitigation Strategy (REMS) for rosiglitazone-containing …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news